Landaas & CO Novartis Ag Transaction History

Landaas & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $42,172 - $48,780	-630 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$64.91 - $73.36 $40,893 - $46,216	630 New	630 $48,000
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $44,345 - $53,014	-630 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $46,708 - $48,680	630	630 $54,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Landaas & CO , based on Form 13F filings with the SEC.

Stay updated on Landaas & CO with notifications on news.